Abstract: Prioritisation methodologies are often used for identifying those pharmaceuticals 22 that pose the greatest risk to the natural environment and to focus laboratory testing or 23 environmental monitoring towards pharmaceuticals of greatest concern. Risk-based 24 prioritisation approaches, employing models to derive exposure concentrations, are 25 commonly used but the reliability of these models is unclear. The present study evaluated 26 the accuracy of exposure models commonly used for pharmaceutical prioritisation. produced similar results in the River Foss. Overall, these findings indicate that PECs may well 37 be appropriate for prioritisation of pharmaceuticals in the environment when robust and 38 local data on the system of interest are available and reflective of most source inputs to the 39 system. 40
Abstract: Prioritisation methodologies are often used for identifying those pharmaceuticals 22 that pose the greatest risk to the natural environment and to focus laboratory testing or 23 environmental monitoring towards pharmaceuticals of greatest concern. Risk-based 24 prioritisation approaches, employing models to derive exposure concentrations, are 25 commonly used but the reliability of these models is unclear. The present study evaluated 26 the accuracy of exposure models commonly used for pharmaceutical prioritisation. Targeted 27 monitoring was conducted for 95 pharmaceuticals in the Rivers Foss and Ouse in the City of 28 York, UK. Predicted environmental concentration (PEC) ranges were estimated based on 29 localised prescription, hydrological data, reported metabolism and wastewater treatment 30 plant (WwTP) removal rates, and were compared to measured environmental 31 concentrations (MECs). For the River Foss, PECs, obtained using highest metabolism and 32 lowest WwTP removal, were similar to MECs. In contrast, this trend was not observed for 33 the River Ouse, possibly due to pharmaceutical inputs beyond our modelling. 34
Pharmaceuticals were ranked by risk based on either MECs or PECs. With two exceptions 35
INTRODUCTION 46
There is increasing concern over the presence and potential effects of pharmaceuticals in 47 the natural environment. The ubiquitous presence of pharmaceuticals in aquatic systems is 48 well-established [1, 2] . Pharmaceuticals are designed to induce a biological response at 49 nanomolar concentrations, raising questions regarding the risk for unintended sub-lethal 50 chronic effects in exposed non-target organisms [3] . Of the approximately 1500 51 pharmaceuticals currently in use in the UK alone, acute ecotoxicity data are available for 52 only a small proportion of these and chronic data are even more scarce [4] . Additionally, 53 little is known about the environmental fate of most pharmaceuticals [5] . Few have 54 undergone extensive fate testing such as quantifying half-lives in environmental matrices, 55 partitioning to sludge, soils, or sediment and uptake into terrestrial and aquatic organisms. 56
Therefore substantial knowledge gaps exist that need to be filled before we can fully 57 understand the effects of pharmaceuticals in the natural environment. To fill these gaps 58 experimentally, however, would require substantial effort in terms of time and cost. 59
Prioritisation methodologies provide a useful tool for identifying which of the thousands 60 of pharmaceuticals in use have the greatest potential to cause unintended effects in non-61 target organisms and which therefore should be experimentally tested in terms of their fate 62 and effects [6] . Several prioritisation approaches have been proposed for pharmaceuticals. 63
For example, hazard-based approaches have involved the prediction of persistence, 64 bioaccumulation, and toxicity of a pharmaceutical and these have then been used to 65 develop an overall hazard score. Compounds with the highest scores are considered to have 66 the highest priority [7] . Risk-based approaches have involved the estimation or 67 measurement of pharmaceutical concentrations in environmental media and thecomparison of these concentrations with an effect endpoint, for example predicted no-69 effect concentrations derived from acute or chronic ecotoxicity data [8 10] or predictions 70
[11], plasma therapeutic concentrations [12] , acceptable daily intakes for humans [13] or a 71 combination of these [4] . Risk-based methods have been identified as preferable due to the 72 consideration of effects and environmental occurrence, ruling out the possibility of 73 prioritising compounds that have little chance of accumulating in the environment at 74 from a wide range of therapeutic classes with different modes of action, an extensive range 115 of chemical and physical properties, high and low usage, as well as select pharmaceuticals 116 not thought to be prescribed in the UK. The city of York (population of 227 000) was chosen 117 as the study system due to the availability of local prescription data, a well-defined and 118 accessible hydrological system (i.e. two rivers that pass through the city), and numerous 119 access points to the rivers via bridges, which enables a detailed characterisation of 120 pharmaceutical concentrations throughout the city. The prioritisation approach used to 121 compare PECs and MECs was based on the Fish Plasma Model (FPM) [12] . Studies of this 122 nature that assess a large range of compounds (95), are an important check on ensuring 123 that priority compounds identified, using common modelling approaches, are comparable 124 to those using environmental data representative of key seasonal, locational, water 125 treatment and hydrological differences. 126
METHODS 127

Study site and sampling 128
We collected and analysed river water samples from eight sites along the Rivers Ouse 129
and Foss in the City of York in the UK where flow conditions were below the long term mean 130 flow and near the Q50 (i.e where flow is equal or exceeded 50% of the time) in February 131 2015 ( Figure 1 ) [30] . Site locations were chosen based on ease of access and their position in 132 relation to WwTP outfalls discharging into these river systems (Supplemental Data, Table  133 S1). Two WwTPs serve the city of York that impact the sampling network. There is a third 134 WwTP; however, it is downstream of the city and sampling points (not included in Figure 1) . 135
The first of these two WwTPs (WwTP A) serves a population of 27 900, employs 136 conventional activated sludge (CAS) as secondary treatment and nitrifying filters as a 137 tertiary treatment option, and the second (WwTP B) serves a population of 18 600 and usestrickling filter technology as secondary treatment paired with biological aerated filtration for 139 tertiary treatment. 140
At each site, three 1-L samples were collected at points distributed equidistant across the 141 width of the river channel and homogenised into a single 1 L composite sample. Three 10-142 mL aliquots were taken from the composite sample and filtered through 0.7 µm glass 143 microfiber (GF/F) disposable filters (Whatman Inc.). To ensure that filtration and field 144 handling of samples did not result in cross-contamination, high-performance liquid 145 chromatography (HPLC)-grade water was also filtered and prepared in the field identically to 146 river samples (i.e. a field blank) three times during the sampling. Samples were frozen 147 directly in the field using dry ice and transported to the U.S. Geological Survey (USGS) 148
National Water Quality Laboratory in Denver Colorado, USA. They arrived four days later 149 and were immediately thawed and analysed. 150
Analytical Methods 151
Samples were analysed using a direct injection (100 µL) high-performance liquid 152 chromatography/tandem mass spectrometry with an electrospray ionization source (LC- and topical preparations, metabolism was assumed to be zero and therefore the F excreta was 210 set to 1 [19] . 211
Wastewater treatment removal was considered in two ways due to the limited 212 availability of removal estimates for all pharmaceuticals in the present study [37] . Firstly, 213 removal values from the literature were collected and, similarly to F excreta estimates, varied 214 substantially (Supplemental Data, Table S5 ). The range of possible WwTP removal estimates 215 were used to calculate a possible PEC range. Secondly, data gaps were filled using the 216
USEPA EPIS e software STPWIN program [38] , similarly to a recent prioritisation exercise 217 in Asia [20] . 218
Evaluation of PECs 219
Separate PEC ranges were calculated for pharmaceuticals for both the River Foss and 220
River Ouse. The PEC range incorporated a river-specific dilution factor reflecting hydrological 221 conditions on the day of sampling. The lowest F excreta and highest WwTP removal values 222 found in the literature were paired to give a minimum PEC, while the maximum was derived 223 using the highest F excreta and lowest WwTP removal found in the literature. A PEC (worst 224 case) was also calculated which only considered site-specific dilution (ie. F excreta = 1, WwTP 225 removal = 0). 226
Prioritisation Approach 227
The fish plasma model (FPM) approach [12, 39] , which has been used in previous 228 prioritisation exercises [6] , was selected as the method used for prioritisation. 
RESULTS AND DISCUSSION 240
Pharmaceutical Occurrence 241
No pharmaceuticals were detected in the field blanks collected indicating that sample 242 collection, handling, and analysis did not result in measurable contamination of the water 243 samples (i.e. protocols did not generate false positives for the present study). Calculated 244 recoveries from quality control matrix spike samples generally fell within 60-120% and were 245 considered acceptable [42] . Recoveries failing to meet these criteria are identified and 246 subsequently interpreted with caution. Reported values were not corrected for percentage 247 of analyte recovered in environmental matrix spikes [43] . The median matrix recovery was 248 88% while the 25 and 75 percentiles were 81 and 160% respectively; this distribution 249 suggests that some matrix enhancement of compound recoveries is occurring. Table 1 . 262
The concentrations and number of detections between the Rivers Ouse and Foss varied 263 ( Fig. 2) with concentrations of six pharmaceuticals in the River Foss being significantly higher 264 O S T-test, p < 0.05). A greater number of and more consistent 265 detections occurred in the River Foss, (Fig. 2 ) which has both a lower dilution factor and the 266 corresponding WwTP (WwTP B) provides less sophisticated water treatment (trickling filter) 267 compared to the treatment used by WwTP A discharging to the River Ouse (conventional 268 activated sludge). 269
Evaluation of Modelled Concentrations with Monitoring Data 270
The EMEA PEC model describes an annual average concentration for the region the 271 consumption data cover; in general, usage data from the whole of a country is averaged to 272
give a single PEC [4] . Evaluating this approach with localised, temporally limited sampleswould introduce a source of potential error as it has been shown that seasonal usage is 274 important for some pharmaceuticals and that demographics in a specific area may differ 275 substantially from the national average [25, 26] . To reduce these potential biases, local 276 usage data, corresponding to time of sampling, was used. In addition, site-specific dilution 277 factors were incorporated to avoid the use of EMEA [23] default dilution factors (i.e. 10). 278
The WW inhab term could not be refined to actual discharge because both WwTPs are highly 279 variable and discharge measurements were not available for the sampling dates. This 280 permits a focus on other factors that could be affecting the suitability of PECs such as WwTP 281 removal and metabolism. 282
Overall PEC Performance 283
Many pharmaceuticals targeted were not detected in the monitoring campaign, however 284 based on their PECs, this was not unexpected. To assess the overall performance of the 285 PECs, a semi-quantitative approach was taken. Each of the 77 pharmaceuticals for which a 286 PEC could be calculated were sorted into one of four possible categories (Figure 3) . 287
Pharmaceuticals that were expected to be detected in the monitoring campaign (i.e. PEC 288 greater than the corresponding analytical MDL) were sorted into either detected or not 289 detected categories. Similarly, pharmaceuticals not expected to be detected (i.e. PEC less 290 than the respective analytical MDL) were sorted into detected and not detected categories. 291
Overall in the semi-quantitative analysis, the PECs in the two rivers performed well with 79% 292 and 86% of predictions correctly confirmed in the River Foss and Ouse, respectively, by the 293 monitoring data. 294
The large difference in dilution between the two rivers, factors of 17.8 and 540 for the 295 number of expected detections. A larger proportion of expected detections were not 297 identified in our monitoring campaign in the Foss in comparison to the Ouse; it could be that 298 pharmaceuticals were missed by our sampling effort, however our results indicate that 299 pharmaceutical concentrations are stable throughout the River Foss over an 8-hour period 300 
Impact of Metabolism and WwTP Removal Uncertainty on PECs 312
Underestimated PECs: A breakdown of how each pharmaceutical PEC performed in 313 comparison to the MEC is shown for the River Foss (Figure 4 ) and the River Ouse ( Figure 5) . 314
While the overall semi-quantitative performance of PECs in the River Ouse was slightly 315 better than the Foss, these results were not repeated when quantitative data were 316 compared. In the Foss and the Ouse, 38% and 78% respectively, of the MEC ranges were 317 entirely greater than the corresponding PEC range. This drops to 12% and 44% respectively 318 when the PEC (worst case) is considered. The PEC (worst case) does not include metabolism 319 or WwTP removal, only dilution, and when this PEC still falls below the MEC it indicates aproblem with the consumption estimate. The analytical matrix spike recoveries indicated 321 that matrix enhancement is occurring, which could affect the comparisons with PECs. To 322 investigate, each compound with a MEC range greater than the PEC range was theoretically 323 corrected based on the compound specific matrix recovery. All of the theoretically corrected 324 MEC ranges were still greater than the corresponding PEC ranges in the River Ouse and Foss 325 with one exception, erythromycin, where the MEC range corresponded with the top of the 326 PEC range in the River Foss. Therefore we do not expect our results to be significantly 327 altered by the distribution in matrix recoveries. 328
In the River Foss, three pharmaceuticals (dextromethorphan, diphenhydramine and 329 pseudoephedrine) had greater MECs than PEC (worst case) estimates and are all available 330 over-the-counter (OTC). This consumption pathway was not considered in our consumption 331 estimate as we were unable to access data on sales of OTC medicines. As a result, PECs for 332 these pharmaceuticals should be systematically underestimated [2, 24, 27 Our results indicate that consideration of metabolism and WwTP removal is essential 360 when calculating PECs because PEC (worst case) is a large overestimate of actual 361 concentrations in the majority of cases (Figure 4) , also shown by others [6, 10, 22] . In the 362 River Foss, prescription pharmaceuticals are described well using the PEC approach. This is 363 in sharp contrast in the River Ouse, where multiple consumption sources are likely affecting 364 concentrations of the pharmaceuticals in the environment, making it impossible to evaluate 365 the effect of the fate parameters with the current dataset. Further monitoring that 366 incorporates sampling WwTP influents and effluents to compute actual removals will becritical to assessing PECs relative to MECs. In addition, the uncertainty in measured 368 concentrations can be limited by incorporating time-averaged composite samples 369 representative of the average conditions [14] . Further work which includes a seasonal 370 monitoring campaign is suggested to quantify the seasonal variability and magnitude of 371 influence that tourism and post-secondary institutions have on MECs in addition to serving 372 as a check of the findings from the present initial scoping study. 373 374 375
Implications for prioritisation 376
Risk ranking order is important as it dictates which pharmaceuticals are of highest risk 377 and thus, most likely to receive further costly investigations into effects and occurrence [4] . 378
Therefore we evaluated the similarities and differences between risk rankings obtained 379 based on MECs and rankings based on PECs for the River Foss ( Figure 6A ) and River Ouse 380 ( Figure 6B ). In the River Foss, while there was some variability in the ranking position of 381 individual compounds, generally, the rankings based on MECs and PECs followed a similar 382 trend. Compounds identified as highest risk based on MECs also were identified as highest 383 risk based on PECs and those ranked as lower risk based on MECs also ranked as lower risk 384 using PECs ( Figure 6A ). The exceptions were dextromethorphan and diphenhydramine 385 where the rank position was much higher based on MECs than based on PECs. This degree 386 of similarity was not observed in the River Ouse ( Figure 6B ). Eight of the MEC ranks are 387 higher risk than their PEC rank counterparts, which visually, is a more variable but gentler 388 rise ( Figure 6B ). This indicates that the degree in which PECs were underestimated in the 389
River Ouse affects prioritisation ranking order trends.
CONCLUSIONS 391
We have presented real-world monitoring data for a comprehensive set of 95 392 pharmaceuticals in two rivers that run through the city of York, UK. During a snapshot 393 sampling where flow conditions were below the long-term mean and near the Q50 in 394
February 2015, 25 pharmaceuticals were quantified (i.e. detected), 10 of which had not 395 been previously measured in the UK aquatic environment. Site-specific PEC ranges varied up 396 to four orders of magnitude due to the variability in metabolism and WwTP removal values 397 found in the literature. The largest unchanged excretion paired with the lowest WwTP 398 removal approach provided the greatest comparability to measured concentrations. Some 399 of the observed differences between MECs and PECs might be explained by complex social 400 demographics, such as tourism or post-secondary institutions, which are suspected of 401 influencing wastewater loading estimates. When PECs and MECs were used to prioritise the 402 detected pharmaceuticals based on risk, generally the two approaches provided similar 403 ranking outcomes for well-defined systems such as the River Foss, but were less comparable 404 in the more complicated system, the River Ouse. The findings for the Foss, in particular, 405 provide some confidence in the use of PECs in prioritisation exercises for pharmaceuticals. 406 Figure 2 . A heat map of the mean pharmaceutical concentration at each of the 8 sampling sites along the Rivers Ouse and Foss. Numbers refer to the specific sampling sites listed in Figure 1 . Significant differences in concentrations between the River Ouse and Foss were found for the 6 pharmaceuticals that were detected frequently en -test, * indicates a p Figure 3 . A semi-quantitative analysis of PEC performance in the rivers based on the monitoring campaign results. A compound is expected to be detected when the PEC is greater than the respective analytical method detection limit. 
SUPPLEMENTAL DATA 407
